Tuesday, March 2, 2010
Demand for Contract Staffing Grows as Pipeline Ramps Up
BioClinica reported its fourth quarter and full-year 2009 earnings earlier this week. Service revenues for the quarter were almost flat from the fourth quarter 2008 at $14.9 million. Income from continuing operations was $943,000, or $0.06 per fully diluted share, compared with income of $1.7 million for the same period 2008.
Second Wave of Sponsor, CRO Growth Hitting Asia-Pac
ICON has signed an extension to its strategic agreement with Eli Lilly and Company to manage the company’s clinical data management outside the U.S. This extension means that ICON will now also manage Lilly’s needs in Japan in addition to those in Europe, Canada, Latin America, Australia and Asia, which was originally agreed to in November 2008.